H1 Funding: $200M Raised, Series C (2022)

H1 funding overview

H1 is based in New York City. H1 has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in January 2022. The round record for H1 runs through 2022; nothing later has been disclosed. Investors on record include Altimeter Capital, Goldman Sachs Asset Management, Menlo Ventures, IVP, Transformation Capital, Novartis Pharma AG and 4 others. 10 distinct backers are named across the disclosed rounds.

H1 at a glance

Total raised: $200M
Latest round: Series C
Latest round date: January 2022
Headquarters: New York City
Notable investors: Altimeter Capital, Goldman Sachs Asset Management, Menlo Ventures, IVP, Transformation Capital, Novartis Pharma AG, Y Combinator, Joe Montana

Frequently asked about H1 funding

How much has H1 raised?: H1 has raised $200M in total disclosed funding across the rounds on record.
Who has invested in H1?: Altimeter Capital, Goldman Sachs Asset Management, Menlo Ventures, IVP, Transformation Capital, Novartis Pharma AG are named among the investors backing H1.
What was the latest H1 funding round?: The most recent disclosed round is a Series C, announced in January 2022.
Where is H1 based?: H1 is based in New York City.
When did H1 last raise?: The last disclosed H1 round closed in January 2022 at Series C.

Round data for H1 is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in New York City and backer lists below.

H1 Funding: $200M Raised, Series C (2022)

H1 funding overview

H1 at a glance

Frequently asked about H1 funding

Companies related to H1 (32)

Browse related funding lists (7)